Serotype specificity and utility of antibodies 5D8/1 and Cox mAB 31A2 for enterovirus diagnostics
Laiho, J. E.; Zeissler, M.-L.; Morgan, N. G.; Hyoty, H.; Richardson, S. J.
Show abstract
A commercially available antibody, Cox mAB 31A2, raised against the VP1 protein of coxsackievirus B3 (CVB3) has been reported as suitable for the detection of CVB3 in diagnostic samples (Ettischer-Schmid 2016). The authors compared this antibody with the widely used, multi-specific, monoclonal anti-VP1 antibody marketed by Dako (clone 5D8/1) and concluded that clone 5D8/1 should not be used to identify enterovirus infections in diagnostic samples. Rather they suggested that Cox mAB 31A2 is preferable for this purpose. Here we address these issues and show that Cox mAB 31A2 can be used successfully to diagnose CVB3 infection in various cell and tissue samples but we demonstrate that it fails to detect many clinically relevant enterovirus types, thereby limiting its use as a general diagnostic reagent for clinical specimens. Rather, we propose that, when used under carefully controlled conditions, clone 5D8/1 should remain the reagent of choice for such purposes.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses 93%
- Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa 91%
- Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland 91%
Similar papers in this journal
Similar papers in this journal
- Bovine polyomavirus-1 (Epsilonpolyomavirus bovis): An emerging fetal pathogen of cattle that causes renal lesions resembling polyomavirus-associated nephropathy of humans 93%
- The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2 93%
- Intra-host evolution during relapsing parvovirus B19 infection in immunocompromised patients 92%
Similar papers in this journal
- Increasing both specificity and sensitivity of SARS-CoV-2 antibody tests by using an adaptive orthogonal testing approach 89%
- Clinical and laboratory characteristics in outpatient diagnosis of COVID-19 in healthcare professionals in Rio de Janeiro, Brazil 88%
- Progression / remission of Coronavirus disease 2019: Data driven recommendations for repeating SARS-CoV-2 nucleic acid amplification tests. 87%
Similar papers in this journal
- Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant 91%
- An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India 91%
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis) 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.